Favorable Early Response of Secondary Chronic Myeloid Leukemia to Imatinib

  • Dalia Waldman*
  • , Michael Weintraub
  • , Arnold Freeman
  • , Yoram Neumann
  • , Gideon Rechavi
  • , Amos Toren
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Favorable Early Response of Secondary Chronic Myeloid Leukemia to Imatinib'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology